Kumar, S. and Zutshi, S. and Jha, MK. and Chauhan, P. and Saha, B. (2021) Development of the Antileishmanial Vaccine. In: Vaccine Design. Methods in Molecular Biology book series (MIMB, volume 2410), 2410 . Springer, pp. 433-461.

Zutshi , S. and Kumar, S. and Chauhan , P. and Saha, B. (2021) Revisiting the Principles of Designing a Vaccine. In: Vaccine Design. Methods in Molecular Biology book series (MIMB, volume 2410), 2410 . Springer, pp. 57-91.

Zutshi , S. and Sarode, A. and Ghosh, SK. and Jha, MK. and Sudan, R. and Kumar, S. and Sadhale, LP. and Roy, S. and Saha, B. (2021) LmjF.36.3850, a novel hypothetical Leishmania major protein, contributes to the infection. Immunology, 163. pp. 460-477.

Zutshi, S. and Kumar, S. and Sarode, A. and Roy, S. and Sarkar, A. and Saha, B. (2019) Leishmania majorAdenylate kinase immunization offers partial protection to a susceptible host. Parasite Immunology., 42 (2).

Kumar, S. and Zutshi, S. and Patidar, A. and Bodhale, N. and Roy, S. and Sarkar, A. and Saha, B. (2019) LmjMAPK10offers protection against Leishmania donovani infection. Parasite Immunology.

Zutshi, S. and Kumar, S. and Chauhan, P. and Bansode, Y. and Nair, A. and Roy, S. and Sarkar, A. and Saha, B. (2019) Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments. Vaccines (Basel), 7 (4).